Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![CanuckCapital5 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1676501080673505282.png) Canuck Capital [@CanuckCapital5](/creator/twitter/CanuckCapital5) on x XXX followers
Created: 2025-07-25 12:37:02 UTC

@Biotech2k1 Biovaxys is interesting. They're strong in immunotherapy, and their recent acquisition of IMV's DPX platform could really boost their cancer and vaccine programs. $BIOV $BVAXF


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948724171900682375/c:line.svg)

**Related Topics**
[$bvaxf](/topic/$bvaxf)
[$biov](/topic/$biov)
[acquisition](/topic/acquisition)

[Post Link](https://x.com/CanuckCapital5/status/1948724171900682375)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

CanuckCapital5 Avatar Canuck Capital @CanuckCapital5 on x XXX followers Created: 2025-07-25 12:37:02 UTC

@Biotech2k1 Biovaxys is interesting. They're strong in immunotherapy, and their recent acquisition of IMV's DPX platform could really boost their cancer and vaccine programs. $BIOV $BVAXF

XXX engagements

Engagements Line Chart

Related Topics $bvaxf $biov acquisition

Post Link

post/tweet::1948724171900682375
/post/tweet::1948724171900682375